SHARE
Lyme Disease Diagnostic Devices Market

Lyme Disease Diagnostic Devices Market Forecasts to 2028 – Global Analysis By Diagnostic Test, Diagnostic Technology Type, End User (Clinical Research Institute, Hospitals, Pharmaceutical Industries, and others) and By Geography

4.2 (59 reviews)
Published: July 2021 ID: SMRC20699
4.2 (59 reviews)
Published: July 2021 ID: SMRC20699

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Lyme Disease Diagnostic Devices Market is accounted for $840.29 million in 2020 and is expected to reach $1,613.86 million by 2028 growing at a CAGR of 8.5% during the forecast period. Upsurge in incidence of Lyme disease, growing policy attention on improving health care services, and the advent of new diagnostic tests for Lyme disease are driving the market growth. However, lack of knowledge of the disease and ineffectiveness in Lyme disease research are hampering the growth of the market.

Lyme disease is a vector-borne illness which is spread by infected ticks. It is not easy to diagnose for many reasons, such as inflammation, dizziness, fatigue, joint or body pains, headaches that are quite common with other diseases, including circular red rash termed as erythema migrants (EM), which doesn’t appear commonly. Hence, it is important to have the advanced diagnostic tool to discover potential targets of Lyme disease instantaneously. There is a substantial need to design rapid, point-of-care tests to determine whether patients are infected with ‘Borrelia burgdorferi’, the bacterium that causes Lyme disease, as early active assessment is imperative to detect to make prompt treatment.

Based on the end user, the hospitals segment is going to have lucrative growth during the forecast period. Hospitals are well-equipped to handle patient flow and employ latest diagnostic and treatment techniques. These factors are primarily responsible for the greater market share of hospitals. By geography, North America is going to have high growth during the forecast period owing to high incidence of Lyme disease and existence of state-of-the-art healthcare infrastructure.

Some of the key players profiled in the Lyme Disease Diagnostic Devices Market include Abbott Laboratories, Affymetrix Inc., Alere Inc (ALR), Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon U.S. Life Sciences, Covance Inc., Fresenius Medical Care AG and Co., GlaxoSmithKline Pharmaceuticals Ltd., Graphene Frontiers, Immunetics Inc., Roche Diagnostics International Ltd., Siemens AG and T2 Biosystems.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 840.29 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

8.5%

Predicted 2028 Value:

USD 1,613.86 million

Forecast Years:

2021-2028

Tables, Graphs& Figures

180

Chapters Covered:

Diagnostic Test, Diagnostic Technologies Type, End User and Region

Core Drivers and Opportunities:

  • Upsurge in incidence of Lyme disease
  • Growing policy attention on improving health care services
  • Advent of new diagnostic tests for Lyme disease

Restraining Factors & Market Threats:

  • Lack of knowledge of the disease
  • Ineffectiveness in Lyme disease research


Diagnostic Tests Covered:
• Serological Test
• Dark Field Microscopy
• Immunofluorescent Staining
• Lymphocytic Transformation Test
• Nucleic Acid Amplification
• Polymerase Chain Reaction (PCR) Analysis
• Urine Antigen Tests

Diagnostic Technologies Types Covered:
• Brain Magnetic Resonance Imaging (MRI)
• Echocardiogram
• Electrocardiogram
• Flow Cytometry
• Gel Microdroplets
• Molecular Diagnostics
• Monoclonal Antibodies
• Spinal Tap  

End Users Covered:
• Clinical Research Institute
• Hospitals
• Pathology Labs
• Pharmaceutical Industries
• Physician’s Office
• Public/Private Laboratories   

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Lyme Disease Diagnostic Devices Market is majorly driven by upsurge in incidence of Lyme disease, growing policy attention on improving health care services, and the advent of new diagnostic tests for Lyme disease.

The brain magnetic resonance imaging (MRI) segment is growing at a highest CAGR owing to the diagnosis of Lyme Neuroborreliosis (LNB) in brainstem and medulla owing to numerous case reports elaborate that LNB has a huge spectrum of imaging entities in patients.

North America dominated with a significant market share due to the factors such as mounting Lyme disease cases, which also has a constellation of symptoms, have been challenging to diagnose.

Europe market is growing at a highest CAGR owing to rising Lyme disease cases, and a great need to design rapid point-of-care technologies to determine the Lyme infection.

Key players in Lyme Disease Diagnostic Devices Market include Abbott Laboratories, Affymetrix Inc., Alere Inc (ALR), Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon U.S. Life Sciences, Covance Inc., Fresenius Medical Care AG and Co., GlaxoSmithKline Pharmaceuticals Ltd., Graphene Frontiers, Immunetics Inc., Roche Diagnostics International Ltd., Siemens AG and T2 Biosystems.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials